Answers are grounded in this paper and cite their sources.
Salima Tariq, Syed M Tariq; Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?,
No takes yet. Share an insight, caveat, or question.
Salima Tariq (1993) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: